Investment Summary

Ardian and Idinvest Partners Invest In Phaxiam Therapeutics

On December 2, 2006, private equity firms Ardian and Idinvest Partners invested in life science company Phaxiam Therapeutics

Investment Highlights
  • This is Ardian’s 2nd and Idinvest Partners’ 1st transaction in the Life Science sector.
  • This is Ardian’s 45th and Idinvest Partners’ 11th transaction in France.
Investment Fate
  • Phaxiam Therapeutics went public in 2013.
  • Phaxiam Therapeutics was sold to a financial buyer in 2017.
  • Phaxiam Therapeutics was sold to a financial buyer in 2025.

Investment Summary

Date 2006-12-02
Target Phaxiam Therapeutics
Sector Life Science
Investor(s) Ardian
Idinvest Partners
Deal Type Growth Capital

Target

Phaxiam Therapeutics

Lyon, France
Phaxiam Therapeutics is a biopharmaceutical company providing new prospects for cancer patients, particularly those with acute leukemia and selected solid tumors. Phaxiam Therapeutics was founded in 2004 and is based in Lyon, France.

Search 214,877 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 2

Investor

Ardian

Paris, France

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1996
PE ASSETS 127.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Ardian is a mega-sized diversified investment group focused on opportunities worldwide. Ardian invests across and manages funds focused on small and mid-sized buyouts, growth capital financings, mezzanine, infrastructure, real estate, and co-investment opportunities. Ardian's small-buyouts group targets controlling interests in French, German, and Italian businesses valued up to €100 million. It's mid-sized buyout group seeks businesses valued up €1.5 billion and does not have any geographic limitations. The Infrastructure team looks for European opportunities and can commit up to €1 billion per transaction. The Mezzanine group supports junior capital commitments of €5 to €80 million. In addition to direct investing, Ardian also manages various private equity fund-of-funds. Ardian was founded in 1996 and is based in Paris.


DEAL STATS #
Overall 74 of 465
Sector: Life Science M&A 2 of 17
Type: Growth Capital M&A Deals 8 of 66
Country: France M&A 45 of 207
Year: 2006 M&A 37 of 37
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-11-28 CABB

Sulzbach am Taunus, Germany

CABB is a vertically integrated global supplier of fine and specialty chemicals and customer manufacturing solutions for the agrochemicals, pharmaceuticals, personal care, and food markets. CABB was founded in 2003 and is based in Sulzbach am Taunus, Germany.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-01-01 Artefact

Paris, France

Artefact is an independent international performance agency, provides digital marketing services primarily in France. Artefact was founded in 1998 and is headquartered in Paris, France.

Sell -
Investor

Idinvest Partners

Paris, France

Category Private Equity Firm
Founded 1997
PE ASSETS 7.6B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Idinvest Partners is a European investment firm focused on investing in small to mid-sized companies at various stages of development. Idinvest segments its investment activity into three groups. These include venture and growth capital, private debt, and dedicated portfolios/funds. Idinvest's venture and growth capital group looks to invest directly in early stage companies with high growth potential. Idinvest's private debt group seeks to provide senior or subordinated debt to small and mid-sized companies pursuing growth objectives. Idinvest's dedicated portfolio/funds group looks to invest in private equity funds, acquire secondary fund positions, and directly co-invest alongside other private equity firms in established companies. Idinvest Partners was formed in 1997 and is based in Paris.


DEAL STATS #
Overall 14 of 78
Sector: Life Science M&A 1 of 10
Type: Growth Capital M&A Deals 3 of 32
Country: France M&A 11 of 56
Year: 2006 M&A 6 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-06-29 Clear2Pay NV/SA

Diegem, Belgium

Clear2Pay develops innovative payment technology for financial institutions, aimed at the safe, timely and smooth processing of internal payment traffic. Clear2Pay invests around EUR 5 million a year in researching and developing innovative payment technologies for use on a global scale.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-12-06 Yoona

Paris, France

Yoona is a search engine, provides on-line help, guides, and suggestions to web users. Yoona was founded in 1995 and is based in Paris, France.

Buy -